NEW YORK, May 15, 2014 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (OTCQB:AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's disease, other diseases of the central nervous system (CNS) and various types of cancer, today provided a business update including clinical trial plans for its lead drug candidates in Alzheimer's disease (AD). - See more at: http://www.globenewswire.com/news-release/2014/05/15/636743/10081859/en/Anavex-Provides-Business-Update-Including-Clinical-Trial-Plans-for-ANAVEX-PLUS-in-Alzheimer-s-Disease.html#sthash.768i4KeB.dpuf
Help employers find you! Check out all the jobs and post your resume.
